// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Iron Deficiency Anemia and Ischemic Stroke in Patients With Pulmonary Arteriovenous Fistulas

Karan Topiwala - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Anemia

N/A

Statin Therapy is Associated With Lower Mortality One Year After Ischemic Stroke

Kadie-Ann Sterling - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Clinical Variables, Electrocardiogram Parameters and Blood Biomarkers Associated With Atrial Fibrillation Detection in the First Year After Ischaemic Stroke - A Systematic Review and Meta-Analysis

Alan Cameron - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Neuroprotection by Remote Ischemic Conditioning in the Setting of Acute Ischemic Stroke

Maryna V Basalay - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Understanding the Role of Microglial Il-1α After Stroke

Eloise Lemarchand - International Stroke Conference (ISC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Collagenase

Sustained Response Outcomes from a Phase IIA, Randomized, Double-blind, Placebo-controlled Study of LY2951742, a Monoclonal Antibody to Calcitonin Gene-related Peptide for the Prevention of Migraine: A Post-hoc Analysis

David Dodick - Pain Week Conference , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Migraine

Calcitonin

Onset of Efficacy of LY2951742 in Migraine Prevention: Data from a Phase IIA, Randomized, Double-blind, Placebo-controlled Study of a Monoclonal Antibody to Calcitonin Gene-related Peptide (A Post-hoc Analysis)

Peter Goadsby - Pain Week Conference , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Migraine

Calcitonin

Preclinical and Clinical Assessments of the Abuse Potential of the Kappa-Opioid Receptor Agonist CR845 Suggest Low Abuse Potential

Frdrique Menzaghi - Pain Week Conference , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Butorphanol

Content Validity of the Penn Facial Pain Scale: Cognitive Debriefing in Patients with Trigeminal Neuralgia

T Symonds - Pain Week Conference , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Efficacy and Safety of LY2951742 in a Randomized, Double-blind, Placebo-controlled, Dose-ranging Study in Patients with Migraine

Tina Oakes - Pain Week Conference , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Migraine

LY2951742

Cholecystectomy for cholecystiti Delayed surgery minimises conversion and 30 day complication rate

- International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of blood transfusion on outcomes following resection of intrahepatic cholangiocarcinoma

A.L. Young - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

The reliability of intraoperative cholangiography at detecting choledocholithiasis in patients presenting with acute gallstone pancreatitis

T. Pike - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gallbladder disease

N/A

A case-series review of symptomatic presumed benign liver cysts that reveal more complex pathology at surgery

H.S. Watson - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A prospective audit of local ERCP practice: Single centre experience

T. Hussain - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laparoscopic CBD exploration and the long-term effect of ante-grade biliary stents

E. Dorrian - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Low serum albumin and positive lymph nodes predict poor outcome in cholangiocarcinoma

M.A. Gani - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

The effectiveness of perioperative antibiotics to reduce surgical site infections following cholecystectomy: A systematic review and meta-analysis

M. Boal - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is cholecystostomy a good alternative treatment for acute cholecystitis in high risk patients?

E. Khalifa - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Surgery for benign histology is associated with worse perioperative outcomes compared to malignant histology in patients undergoing Whipple's pancreaticoduodenectomy for pancreatic head mass

V. Mavroeidis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved